0001209191-23-040299.txt : 20230630
0001209191-23-040299.hdr.sgml : 20230630
20230630160800
ACCESSION NUMBER: 0001209191-23-040299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUBIN STEVE
CENTRAL INDEX KEY: 0001265123
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 231061774
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-30
0
0001720580
Adicet Bio, Inc.
ACET
0001265123
DUBIN STEVE
C/O ADICET BIO, INC.
200 BERKELEY STREET, 19TH FLOOR
BOSTON
MA
02116
1
0
0
0
0
Common Stock
2023-06-30
4
P
0
5000
2.3999
A
10900
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $2.3997 to $2.3999, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the Securities and Exchange Commission staff upon request.
/s/ Nick Harvey, Attorney-in-Fact
2023-06-30